Top Banner
BOWEL MOVEMENT Presented by : Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by : Prof. Riaz Qureshi, FRCGP
37

Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

Dec 22, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

BOWEL MOVEMENT

Presented by:Abdullah Al-Ruwaita

Abdullah Al-Manea

Yousif Al-Ansari

Supervised by:Prof. Riaz Qureshi, FRCGP

Page 2: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

Bowel movement

Normal Abnormal

Constipation Diarrhea

acute

Chronic

Page 3: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

CONSTIPATION Dif: hard, dry, lumpy stools that are difficult or

painful to pass

Causes:

- Congenital or Primary.

- Secondary which includes:-Insufficient dietary fiber intake.

-Inadequate fluid intake.

-Decreased physical activity.

-Side effects of medications.

-Hypothyroidism.

-Obstruction by colorectal cancer.

Page 4: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

ACUTE DIARRHEA Dif: three or more loose or watery stools per

day, without abdominal bloating, pressure, and cramps commonly referred to as gas.

Causes:• Infections:

-Viral -Bacterial

- -Parasites• Intestinal disorders• Reaction to certain medications

Page 5: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

CHRONIC DIARRHEA Dif: as loose stools that last for at least

four weeks, usually means three or more loose stools per day.

Causes:- Irritable bowel syndrome- Inflammatory bowel disease - Malabsorption syndromes- Chronic infections. 

Page 6: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

Chronic diarrhea

Irritable bowel

syndrome

Inflammatory Bowel

Disease

Ulcerative colitis

Crohn's disease

Celiac Disease

Lactose intolerance

Page 7: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

1 -IRRITABLE BOWEL SYNDROME Dif: is a gastrointestinal syndrome

characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause. It is the most commonly diagnosed gastrointestinal condition.

Page 8: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

EPIDEMIOLOGY prevalence of IBS in North America

estimated from population-based studies is approximately 10 to 15 percent

in Europe found an overall prevalence of 11.5 percent

2:1 female:male

Page 9: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

CLINICAL MANIFESTATIONS 

Chronic abdominal pain (as a crampy sensation and abdominal pain)

Altered bowel habits (ranging from diarrhea, constipation)

- Diarrhea (frequent loose stools of small, fecal incontinence and feeling of incomplete evacuation)

- Constipation (Stools are often hard, may last from days to months)Other gastrointestinal symptoms 

Other gastrointestinal symptoms (Upper GI symptoms)

Page 10: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

DIAGNOSTIC CRITERIA  Rome III diagnostic criteria: Recurrent abdominal pain or discomfort. at least 3 days per month in the last 3 months

associated with 2 or more of the following:

(1) Improvement with defecation

(2) Onset associated with a change in frequency of stool

(3) Onset associated with a change in form (appearance) of stool

Page 11: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

DIAGNOSTIC APPROACH  many disorders present with similar

symptoms (r/o), Routine laboratory studies (complete

blood count, chemistries) are normal in IBS.

Page 12: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

"Alarm" or atypical symptoms which are not compatible with IBS include (red flags) :

• Rectal bleeding• Nocturnal or progressive abdominal pain• Weight loss• Laboratory abnormalities such as anemia,

elevated inflammatory markers, or electrolyte disturbances

Patients with one of these alarm symptoms require further imaging studies and/or colonoscopy

Page 13: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

CAUSES It is not clear why patients develop IBS. Sometimes it

occurs after an infection of the intestines. This is called post-infectious IBS. There may also be other triggers;

Brain-gut signal problems (thalamic activity). GI motor problems (unpleasant stimuli). Hypersensitivity (stimulation of various receptors

in the gut wall). Mental health problems (Such as anxiety,

depression). Bacterial gastroenteritis. Small intestinal bacterial overgrowth.  Food sensitivity (food intolerance to certain foods). Child Abuse

Page 14: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

DIFFERENTIAL DIAGNOSIS Crohn's disease Ulcerative colitis Diverticulosis Celiac Disease Lactose intolerance Colon malignancy Peptic ulcer disease Biliary liver disease Chronic pancreatitis Medications Lymphoma of the GI

Page 15: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

TREATMENT Patient education:Education of the proposed mechanisms of IBS helps to validate the patient's illness experience and sets the basis for therapeutic interventions

Page 16: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

Dietary modification: dietary history may reveal patterns of symptoms related to specific foods.

- Lactose (similarity that may occur in symptoms of IBS and lactose intolerance, an empiric trial of a lactose free diet should be considered )

- Exclusion of gas-producing foods - Food allergies - Gluten sensitivity - Carbohydrate malabsorption - Fiber (increase in the intake of fiber is often recommended)

Page 17: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

Physical activity 

Psychosocial therapies - Cognitive behavior therapy- Relaxation training- Gut-directed Hypnotherapy

Page 18: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

MEDICATIONS:- Antispasmodic agentso Mebeverineo Alverineo Dicyclomine (an anticholinergic)- Antidepressants (TCAs, SSRIs)

Page 19: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

TAKE HOME MESSAGE Mind and body often combine to

increase the distress of IBS patients.

Psychological intervention worth considering.

IBS patients can be managed well by family physicians.

Don’t forget “red flags” for referral to GI specialist is a must !

Page 20: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

Chronic diarrhea

Irritable bowel

syndrome

Inflammatory Bowel Disease

Ulcerative colitis

Crohn's disease

Celiac Disease

Lactose intolerance

Page 21: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

INFLAMMATORY BOWEL DISEASE Inflammatory bowel disease (IBD) is comprised

of two major disorders:

1.Ulcerative colitis (UC).2.Crohn's disease (CD).

•IBD can present at any age: –The peak :15 - 30 years. – A second peak 50

•Etiology is unknown but there are 3 main factors contributing to it : Genetic factors, environmental factors, diet.

Page 22: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

1 -ULCERATIVE COLITIS Ulcerative colitis is characterized by

recurring episodes of inflammation limited to the mucosal layer of the colon.

•major symptoms of UC are: -Diarrhea -rectal bleeding     ( usually fresh blood )  -Tenesmus -passage of mucus -crampy abdominal pain

Page 23: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

DIAGNOSIS : No single modality is enough for Diagnosis .

Combination of clinical picture, laboratory,  Endoscopy, pathology.

Colonscopy findings: –The vascular markings are lost, petechiae, exudates,

touch friability, and frank hemorrhage may be present.

–In Pathology,  biopsy shows : –Crypt abscesses. –chronic changes including branching of crypts,

atrophy of glands, and loss of mucin in goblet cells

Page 24: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

MANAGEMENT: –Rule out infection

–5 ASA (5-amino salicylic acids)-  therapy: •Rectal ( if the UC extend less than 20 cm ) •Oral ( if the UC extend more than 20 cm +) in combination

with rectal 

–Corticosteroids:  •Systemic: Prednisolone •Local acting: enema.

–Immunomodulators : •Azithyoprine •Methotrexate

–Anti TNF therapy

Page 25: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

2 -CROHN'S DISEASE  Is a disorder of uncertain etiology that is

characterized by transmural inflammation of the gastrointestinal tract.

SYMPTOMS: –Fatigue. –Diarrhea.  –Abdominal pain. –Weight loss. –Fever. –Bleeding is very rare.

Page 26: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

DIAGNOSIS: Colonoscopy: • Endoscopic features include focal ulcerations adjacent to

areas of normal appearing mucosa along with polypoid mucosal changes that give a cobblestone

Wireless capsule endoscopy 

Serologic markers  •Inflamatory marker : ESR, CRP •Antibody tests : •Antineutrophil cytoplasmic antibodies (pANCA) > with UC •Anti-Saccharomyces cerevisiae antibodies (ASCA)  > with

CD Stool markers — fecal calprotectin.

Page 27: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

COMPLICATIONS:The intestinal complications of Crohn's disease

include the following :-Intestinal obstruction

-Fistulas -Abscess

-Hemorrhage (bleeding) - Unusual in Crohn's disease -Malabsorption

-Carcinoma, Colonic disease increases risk of colon cancer

The longer you have Crohn's disease, the more likely you are to develop complications that can be fatal.

Page 28: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

TREATMENT:The goals of treatment of Crohn's disease are

to reduce the underlying inflammation, which then relieves symptoms, prevents complications, and maintains good nutrition.

Aspirin-like anti-inflammatory drugs (mesalamine) reduce the inflammation.

Corticosteroids reduce inflammation and suppress the immune system.

Antibiotics reduce inflammation indirectly by reducing infection.

Immunosuppressants suppress the immune system.

Surgery. (alternative) .

Page 29: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

CELIAC DISEASE Celiac disease is a medical condition in which the

absorptive surface of the small intestine is damaged by a substance called gluten. This results in an inability of the body to absorb nutrients: protein, fat, carbohydrates, vitamins and minerals, which are necessary for good health.

SYMPTOMS: –anemia. –chronic diarrhea. –weight loss. –Fatigue. –cramps and bloating. –irritability.

Page 30: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

DIAGNOSIS: Screening

Biopsy: A definitive diagnosis can only be made by a small bowel biopsy.

Page 31: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

TREATMENT: Celiac disease as yet has no known

cure, but can usually be effectively treated and controlled. The treatment of celiac disease is strict adherence to a GLUTEN FREE DIET FOR LIFE.

Page 32: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

LACTOSE INTOLERANCE Lactose intolerance means the body

cannot easily digest lactose, a type of natural sugar found in milk and dairy products. Lactose intolerance occurs when the small intestine does not make enough of an enzyme called lactase.

Lactose intolerance most commonly runs in families, and symptoms usually develop during the teen or adult years.

It could be temporary 

Page 33: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

SYMPTOMS: Symptoms of lactose intolerance can be mild

to severe, depending on how much lactase the body makes. Symptoms usually begin 30 minutes to 2 hours after eating or drinking milk products. symptoms may include:

•Bloating. •Pain or cramps. •Gurgling or rumbling sounds in your belly. •Gas. •Loose stools or diarrhea. •Throwing up.

Page 34: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

DIAGNOSIS: medical history.

To confirm a diagnosis: -Hydrogen breath test -Lactose tolerance test

Page 35: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

TREATMENT: Fortunately, lactose intolerance is

relatively easy to treat. No known way exists to increase the amount of lactase enzyme the body can make, but symptoms can be controlled through diet.

Page 36: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

ROLE PLAY >> CASE SCENARIO

Who is ready ?

Page 37: Presented by: Abdullah Al-Ruwaita Abdullah Al-Manea Yousif Al-Ansari Supervised by: Prof. Riaz Qureshi, FRCGP.

THANK YOU

Questions ?